<?xml version="1.0" encoding="UTF-8"?>
<p>
 <bold>Ferric reducing antioxidative </bold>
 <bold>‎</bold>
 <bold> power. </bold>Ferric reducing antioxidative ‎ abilities of EOs and BHT were assessed with standard protocol and outcomes were reported in μM equivalent to FeSO
 <sub>4</sub>.7H
 <sub>2</sub>O. Four studied EOs were capable of chelating iron (II). Absorbance (at 593 nm) of various concentrations of Fe
 <sub>2</sub>SO
 <sub>4 </sub>including 31.25, 62.50, 125, 250, 500; and 1000 mmol L
 <sup>-1</sup>) in FRAP assay were 0.15, 0.22, 0.33, 0.59, 1.07; and 2.00, respectively. The FRAP assay is based on the reduction of colorless Fe
 <sup>3+</sup> compounds into Fe
 <sup>2+</sup> tripiridyltriazine in the existence of the antioxidant.
 <sup>
  <xref rid="B22" ref-type="bibr">22</xref>
 </sup> The antioxidative ‎ capacity in the different concentrations of EOs is presented in 
 <xref ref-type="fig" rid="F1">Figure 1B</xref>. The FRAP values of BHT, OEO, ZEO, SEO, and CEO were respectively 2.98 ± 0.02, 1.47 ± 0.04, 2.01 ± 0.04, 1.01 ± 0.03; and 0.66 ± 0.34, and the tested EOs showed the highest antioxidative ‎ activity at 2.00 g L
 <sup>-1</sup> (
 <xref ref-type="fig" rid="F2">Fig. 2</xref>).
</p>
